Robert A. Bradway | |
|---|---|
 | |
| Nationality | American |
| Alma mater | Amherst College Harvard University |
| Occupation(s) | Chairman and Chief Executive Officer of Amgen |
Robert A. Bradway is an American businessman. He is the chairman and chief executive officer of Amgen. [1]
Bradway holds a B.S. degree in biology from Amherst College and an MBA from Harvard University. [2]
Bradway joined Morgan Stanley in New York in 1985 as a health care industry investment banker. In 1990 he moved to London, where he was a managing director with responsibility for the firm's banking department and corporate finance activities in Europe. [3] [4]
Bradway joined Amgen in 2006 as vice president of operations strategy, and was executive vice president and chief financial officer from April 2007 to May 2010. [5] He was its president and chief operating officer from May 2010 to May 2012. [6] In October 2011, he was appointed to the Amgen board of directors. Bradway was named CEO of Amgen in May 2012, and chairman of the board in January 2013. [4]
During Bradway’s tenure as CEO, Amgen's annual revenue increased from $17.3 billion in 2012 [7] to $26 billion in 2021, [8] and annual R&D investment increased to $4.2 billion in 2020. [9] Bradway oversaw the acquisition of Iceland-based DeCODE Genetics in 2012, [10] Onyx Pharmaceuticals in 2013, [11] and a 20.5% equity stake in Beijing-based BeiGene in 2020. [12]
Bradway is on the board of directors of Boeing. [13] He gave the 2016 commencement speech at the Keck Graduate Institute, which is part of The Claremont Colleges. [14] He gave the 2017 commencement speech at the UCLA Anderson School of Management, where he is on the board of trustees and on the board of the Leonard D. Schaeffer Center for Health Policy and Economics. [15]
He is the chairman of the CEO Roundtable on Cancer and a member of the American Heart Association CEO Roundtable. [16]
Bradway was a keynote speaker at the 2015 World Medical Innovation Forum. [17] In June 2017, he gave the keynote address at the commencement ceremony for graduates of the University of California, Los Angeles Anderson School of Management. [18] Bradway was a speaker at Fortune magazine's Brainstorm Health virtual conference in June 2020. [19] [20]
Following the 2020 murder of George Floyd in May 2020, Bradway issued a statement condemning the murder as "senseless" and pledging to address racial inequality at Amgen, stating, "Let's take inspiration from science and trust that progress, like knowledge, builds upon itself, incrementally improving on what exists today until the cumulative adds up to something profound." [21]
On October 1, 2020, Bradway testified before the House Oversight Committee and was questioned by Rep. Katie Porter (D. Cal) for his considerable compensation. He and four other top Amgen executives earned a combined $124.2 million over a three-year period spanning 2017–2019. [22]
Keck Graduate Institute (KGI) is a private graduate school in Claremont, California. Founded by Henry Riggs and David Galas in 1997, it is the seventh and newest member of the Claremont Colleges.
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the world's largest independent biotechnology companies, As of 2022, Amgen has approximately 24,000 staff in total.
Kenneth Irvine Chenault is an American business executive. He was the CEO and Chairman of American Express from 2001 until 2018. He is currently the Chairman of the global venture capital firm General Catalyst.
Laurence Douglas Fink is an American billionaire businessman. He is a co-founder, chairman and CEO of BlackRock, an American multinational investment management corporation. BlackRock is the largest money-management firm in the world with more than US$10 trillion in assets under management. In April 2024, Fink's net worth was estimated at US$1.2 billion according to Forbes. He sits on the boards of the Council on Foreign Relations and the World Economic Forum.
Bruce Stanley Kovner is an American billionaire hedge fund manager and philanthropist. He is chairman of CAM Capital, which he established in January 2012 to manage his investment, trading and business activities. From 1983 through 2011, Kovner was founder and chairman of Caxton Associates, a diversified trading company. As of April 2024, his net worth was estimated at US$7.7 billion.
John Edgar Bryson is an American lawyer who was United States Secretary of Commerce from 2011 to 2012, the 37th person to hold the post since its establishment in 1913. Prior to this, he served as the chairman, chief executive officer and president of Edison International, the parent company of Southern California Edison and as director of The Boeing Company. He co-founded the Natural Resources Defense Council with fellow Yale alumni in 1970.
Ursula M. Burns is an American businesswoman. Burns is known for her tenure as the CEO of Xerox from 2009 to 2016. In this role, Burns was the first black woman to lead a Fortune 500 company. She is also the first woman to follow another as the head of a Fortune 500 company. Burns remained the chairman at Xerox from 2010 to 2017.
The Business Roundtable (BRT) is a nonprofit lobbyist association based in Washington, D.C. whose members are chief executive officers of major United States companies. Unlike the United States Chamber of Commerce, whose members are entire businesses, BRT members are exclusively CEOs. The BRT lobbies for public policy that is favorable to business interests, such as lowering corporate taxes in the U.S. and internationally, as well as international trade policy like the North American Free Trade Agreement.
Fred Hassan, is a Pakistan-born American business executive who works for Warburg Pincus and was CEO of three global pharmaceutical companies.
Ellen J. Kullman is a United States business executive. Since November 2019, she has been the chief executive officer of Carbon (company). She was formerly Chair and Chief Executive Officer of E. I. du Pont de Nemours and Company ("DuPont") in Wilmington and is a former director of General Motors. Forbes ranked her 31st of the 100 Most Powerful Women in 2014. Kullman retired from DuPont on October 16, 2015.
Daniel H. Schulman is an American former business executive. He is the former president and CEO of PayPal, and before that group president of enterprise growth at American Express. Schulman was responsible for American Express' global strategy to expand alternative mobile and online payment services, form new partnerships, and build revenue streams beyond the traditional card and travel businesses. Earlier, he was president of Sprint's prepaid group and the founding CEO of Virgin Mobile.
Onyx Pharmaceuticals Inc. has been a biopharmaceutical company headquartered in South San Francisco, California. The company developed and marketed medicines for the treatment of cancer. Onyx was founded in 1992 by Kevin J. Kinsella and Frank McCormick Ph.D., FRS. McCormick served as the chief scientific officer until 1998, while Kinsella was the firm's chairman. In 2009, the company acquired Proteolix, Inc., a private biotechnology company, for $276 million in cash plus additional milestone payments. In January 2012, the company was named "the top biotechnology takeover target in 2012" through an industry survey. Onyx president and chief executive officer (CEO) N. Anthony Coles had said that Onyx liked its prospects as an independent company and was focused on bringing new therapies to patients. However, at the end of August 2013, Amgen announced it was acquiring Onyx in an agreed $10.4 billion deal.
Alex Gorsky is an American businessman. He is the former chairman and CEO of Johnson & Johnson. Gorsky stepped down as CEO of Johnson & Johnson in January 2022 and was succeeded by Joaquin Duato. He was the seventh person who served as the company's chairman and chief executive officer since it became a publicly traded company in 1944. He is a board director of Apple and JP Morgan Chase.
Sherilyn S. McCoy is an American scientist and business executive. She is the former CEO of Avon Products and former vice chairman and member of the office of the chairman of Johnson & Johnson, where she was responsible for the pharmaceutical and consumer business divisions of the company. She was appointed as the vice chairman in January 2011, after which she was named by Fortune Magazine, as the 10th woman on their list of "50 Most Powerful Women in Business", a list on which she has been included since 2008. In February 2012, she resigned her employment with Johnson & Johnson after 30 years and was subsequently named as the CEO of Avon Products. In August 2012, she was recognized as the 39th most powerful woman in the world by Forbes Magazine.
Chris Viehbacher is a German-Canadian businessman. He served as the Chief Executive Officer of Sanofi and Chairman of Genzyme until 29 October 2014. Viehbacher then worked with Gurnet Point Capital, a healthcare venture capital and private equity fund backed by Ernesto Bertarelli and his family.
Mark A. Weinberger is an American businessman. He is the former global Chairman and CEO of EY. Weinberger currently sits on several boards of directors, including those of Metlife, Johnson & Johnson Saudi Aramco. and JPMorgan Chase. Earlier in his career he has also held several posts in the public sector in Washington, D.C., including time as Assistant Secretary of the Treasury for Tax Policy.
Brian C. Cornell is an American businessman, and the chairman and chief executive officer (CEO) of Target Corporation. He is also non-executive chairman of Yum! Brands.
Brendan Peters Bechtel is an American businessman who is the chairman and chief executive officer of Bechtel, the second largest construction company in the United States, which has operations in 160 countries. The great-great-grandson of founder Warren A. Bechtel, he became CEO at the age of 35, and is the fifth generation of the Bechtel family to lead the privately owned company since 1898. Bechtel chairs the infrastructure committee of the Business Roundtable, a lobbying group representing CEOs of some of the largest companies in the country.
Albert Bourla is a Greek-American veterinarian and businessman known for serving as the chairman and chief executive officer of the pharmaceutical company Pfizer. He joined the company in 1993 and has held several executive roles across Pfizer's divisions. Prior to becoming chief executive officer, Bourla was chief operating officer.
N. Anthony Coles is an American physician, biotechnology entrepreneur, and pharmaceutical leader. Since 2018, Coles has served as chair of the board of directors for Cerevel Therapeutics.